StonvexLoading…
StonvexStonvexStonvexCore line items from SYK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $6.64B | $6.02B | $25.12B | $6.06B | $6.02B |
Operating Income | Not available | $936.00M | $4.89B | $3.08B | $1.95B |
Net Income | Not available | $745.00M | $3.25B | $859.00M | $884.00M |
EPS (Diluted) | $3.51 | $1.93 | $8.40 | $2.22 | $2.29 |
Total Assets | Not available | $46.29B | $47.84B | $47.06B | $46.33B |
Total Liabilities | Not available | $23.31B | $25.42B | $25.27B | $25.14B |
Cash & Equivalents | Not available | $2.88B | $4.01B | $3.26B | $2.38B |
Free Cash Flow OCF − CapEx | Not available | $415.00M | $4.28B | $2.41B | $1.05B |
Shares Outstanding | Not available | 386.50M | 386.50M | 386.50M | 386.40M |